Li Wei

600 Yishan Road
Shanghai, 200233, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Single-nucleus transcriptomics identifies SPON1 as a candidate mediator of the anti-fibrotic effect of Abelmoschus manihot (L.) in diabetic kidney disease.

Single-nucleus transcriptomics identifies SPON1 as a candidate mediator of the anti-fibrotic effect of Abelmoschus manihot (L.) in diabetic kidney disease.

Journal: American journal of translational research

Published: February 27, 2026

Efficacy and safety of Abelmoschus manihot in the treatment of patients with type 2 diabetes and microalbuminuria: A multicenter randomized, open-label, parallel-controlled clinical trial.

Efficacy and safety of Abelmoschus manihot in the treatment of patients with type 2 diabetes and microalbuminuria: A multicenter randomized, open-label, parallel-controlled clinical trial.

Journal: Chinese medical journal

Published: September 27, 2025

Diagnostic performance of ultrasound-derived fat fraction for assessing steatotic liver disease with histopathology as the reference.

Diagnostic performance of ultrasound-derived fat fraction for assessing steatotic liver disease with histopathology as the reference.

Journal: Ultrasonography (Seoul, Korea)

Published: August 20, 2025

Exploring the potential mechanisms of OSBPL3 in metabolic dysfunction-associated steatotic liver disease by integrating bulk and single-cell RNA sequencing data.

Exploring the potential mechanisms of OSBPL3 in metabolic dysfunction-associated steatotic liver disease by integrating bulk and single-cell RNA sequencing data.

Journal: Medicine

Published: May 07, 2025

Quantitative ultrasound-derived fat fraction for identifying pediatric patients with metabolic dysfunction-associated steatotic liver disease: a prospective study.

Quantitative ultrasound-derived fat fraction for identifying pediatric patients with metabolic dysfunction-associated steatotic liver disease: a prospective study.

Journal: Pediatric radiology

Published: April 14, 2025

Effect of Skeletal Muscle Mass and Its Associated Mediators on the Development of Steatotic Liver Disease: A Cohort Study in China.

Effect of Skeletal Muscle Mass and Its Associated Mediators on the Development of Steatotic Liver Disease: A Cohort Study in China.

Journal: Journal of cachexia, sarcopenia and muscle

Published: November 28, 2024

Ultrasound-guided attenuation parameter for identifying metabolic dysfunction-associated steatotic liver disease: a prospective study.

Ultrasound-guided attenuation parameter for identifying metabolic dysfunction-associated steatotic liver disease: a prospective study.

Journal: Ultrasonography (Seoul, Korea)

Published: November 12, 2024

Single-cell atlas reveals multi-faced responses of losartan on tubular mitochondria in diabetic kidney disease.

Single-cell atlas reveals multi-faced responses of losartan on tubular mitochondria in diabetic kidney disease.

Journal: Journal of translational medicine

Published: August 02, 2024

Associations between multiple metabolic biomarkers with steatotic liver disease subcategories: A 5-year Chinese cohort study.

Associations between multiple metabolic biomarkers with steatotic liver disease subcategories: A 5-year Chinese cohort study.

Journal: Cell reports. Medicine

Published: February 21, 2024

Hepatic steatosis using ultrasound-derived fat fraction: First technical and clinical evaluation.

Hepatic steatosis using ultrasound-derived fat fraction: First technical and clinical evaluation.

Journal: Clinical hemorheology and microcirculation

Published: August 28, 2023

Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1/PINK1 signaling in tubular cells.

Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1/PINK1 signaling in tubular cells.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: March 23, 2023

A greater ratio of thigh subcutaneous fat to abdominal fat is associated with protection against non-alcoholic fatty liver disease.

A greater ratio of thigh subcutaneous fat to abdominal fat is associated with protection against non-alcoholic fatty liver disease.

Journal: JHEP reports : innovation in hepatology

Published: October 19, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026